Non-ownership Filings
| Update on Licensed Oncology Product in China | Mar. 09, 2026 |
| Directorate change | Mar. 06, 2026 |
| HUTCHMED Initiates Global Trial of ATTC Candidate | Mar. 04, 2026 |
| HUTCHMED to Announce 2025 Final Results | Feb. 06, 2026 |
| Publication of Phase III Results in The Lancet | Jan. 14, 2026 |
| Surufatinib + Camrelizumab PDAC Phase 3 initiation | Jan. 05, 2026 |
| Total Voting Rights | Dec. 31, 2025 |
Ownership Update Filings
| Vesting of awards under Long Term Incentive Plan | Mar. 11, 2026 |
| Vesting of awards under Long Term Incentive Plan | Oct. 21, 2025 |
| Grant of Share Options and Awards under LTIP | Jun. 10, 2025 |
| Vesting of awards under Long Term Incentive Plan | Mar. 14, 2025 |
| Vesting of awards under the LTIP | Oct. 21, 2024 |
| Standard form for notification of major holdings | Aug. 22, 2024 |
| LTIP and Share Option Scheme | Aug. 06, 2024 |